Centre for Design and Synthesis of Molecularly Targeted Radiopharmaceuticals (CERAD)
2019.05.20 - Marek Pawłowski Between 13th and 17th of May the second meeting on coordinating research of new 99mTc production methods and 99mTc generators was held in Świerk as a part of the programme of the International Atomic Energy Agency. Guests from several countries from five continents have discussed various aspects related to satisfying the needs of patients all over the world for this basic isotope in nuclear medicine.
2018.12.04 - Marek Pawłowski Associate Professor Engineer Renata Mikołajczak (POLATOM@NCBJ) joined the International Scientific Committee of ARRONAX institute in France. Institute, the name of which is an abbreviation of Accelerator for Research in Radiochemistry and Oncology at Nantes Atlantic possesses a cyclotron with energy up to 70 MeV used mainly for production of strontium-82, as well as germanium-68 and astatine-211. Experience in production of the last of these isotopes can be very valuable for cyclotron CERAD constructed in Świerk.
2018.10.09 - Marek Pawłowski On 4th October doctorate studies were inaugurated in Świerk under RadFarm project - Radiopharmaceuticals for molecularly targeted diagnostics and medical therapy. 17 listeners will be attending the lectures and led their own research in four cooperating scientific units. The course is co-funded by National Centre for Research and Development's POWER programme.